Lime Therapeutics

Lime Therapeutics is the lipids company. We reversing lysosomal lipid dysfunction due to aging, environment, and genetic mutations in cancer and cardiometabolic disorders. We have developed a first-of-its-kind real-time lipid-detection platform, LipidSense™, to identify new targets and screen for novel drug candidates. In addition to our internal cancer drug discovery efforts, we have a partnership with Novo Nordisk in the field of atherosclerosis. In the future, Lime will expand its therapeutic development efforts in neurodegeneration, liver disease, and lysosomal storage disorders.